prevalence of comorbidities in a cohort of Egyptian RA Patients.

What is it about?

Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study- level of application of recommendations related to detection/prevention of comorbidities.

Featured Image

Why is it important?

It is increasingly recognized that comorbid conditions arecommon in RA population [1], with an impact on RA out-come [2]. There is increased risk of premature mortality com-pared with the general population, primarily due to an in-creased incidence of cardiovascular disease (CVD), particu-larly coronary artery disease [3]. Several other RA-relatedcomorbidities, including, infection, osteoporosis, lymphopro-liferative malignancies, and peptic ulcer disease, serve as major determinants of disease-associated outcome